Alzheimer's Society UK Dementia Trials Network Research Nurse

The purpose of the role is to expand and enable access to early phase dementia and mild cognitive impairment clinical research studies. In this role, you'll be part of a supportive, multidisciplinary team driving forward expansion of early phase dementia and neurodegenerative clinical research. You'll help deliver a range of early phase trials and play an active role in reaching and engaging underserved communities, raising awareness and making sure everyone has the opportunity to take part in high quality research where available and appropriate to their care.

This role is funded by the UK Dementia Trials Network, supported as part of the Alzheimer's Society UKDTN Research Nurse programme, and hosted by ReMind UK. At ReMind UK, our research helps improve the lives of people affected by neurodegenerative conditions such as Alzheimer's disease. We're looking for someone who is proactive, collaborative and flexible, someone who enjoys working with others and is excited to contribute to the newly established UK Dementia Trials Network and Alzheimer's Society UKDTN Research Nurse programme. Together, we'll continue to push for progress, share expertise and make a real difference for the people and families we support.

Main duties of the job:

• Play a key role in the provision of effective nursing services for optimal early phase trial delivery.
• Provide clinical and administrative support as Study Coordinator on trials and be closely involved from clinical start-up at the Site Initiation Visit right through to close-out.
• Work closely with the Principal Investigator and collaboratively with the wider study team to ensure high quality research delivery, ensuring participants and their study partners are supported throughout.

Hours of work are normally 9.00am to 5.00pm, with 30 minutes lunch, but some flexibility is required. Occasional out of hours or overnight work may be necessary, for example, if related to a particular research project.

Key Responsibilities:

• Ensure the smooth delivery of early phase dementia clinical trials by effectively coordinating and delivering participant study visits in line with all applicable research governance requirements, regulations and legislation.
• Promote safety and study integrity through monitoring of participants during study procedures and accurate recording of any adverse events and concomitant medications.
• Immediately report, using the appropriate procedures, Serious Adverse Events (SAEs) and Suspected Unexpected Serious Adverse Reactions (SUSARs).
• Collaborate with sponsors to ensure day-to-day study operations and support effective monitoring visits.
• Improve recruitment and retention by actively supporting participant engagement with a particular focus on underserved communities.
• Maintain high quality research data through accurate collection, documentation, and medication accountability.
• Sample processing including preparing, centrifuging, and coordinating transport and storage of blood and biological specimens.
• Accurate recording of electrocardiograms and patient observations/vital signs.
• Liaise with laboratories and radiology departments to ensure appropriate investigations are scheduled and conducted per protocol.
• Support study set-up and delivery by ensuring all research equipment and supplies are available, maintained, and appropriately calibrated.
• Ensure safe and compliant medication administration under medical direction.
• Represent the study site professionally by attending site initiation and investigator meetings, including international meetings when required.
• Co-ordinate and manage research within expected timelines and to meet recruitment targets agreed with Investigators, UKDTN and Alzheimer's Society.
• Collaborate with Alzheimer's Society, UKDTN sites, community groups, local Trusts and regional memory and mental health services to strengthen referral pathways and improve access to early phase dementia clinical research.
• Compile and contribute to ReMind UK early phase dementia and mild cognitive impairment research activity reports.
• Work in line with UKDTN and Alzheimer's Society objectives to support delivery of strategic key performance indicators.
• Maintain UKDTN live capacity and capability database for ReMind UK.